Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0605-2018

Drug recall · April 4, 2018

Flucanazole Injection recall

Why: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

Lots / codes

Lot A060644, May 2018

Quantity
1277 bags
Company
Renaissance Lakewood, LLC, Lakewood, NJ
Distribution
Nationwide
Initiated
March 2, 2018 · Voluntary: Firm initiated
Classified
March 23, 2018
Reported
April 4, 2018
Ended
April 10, 2020
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.